GANDEEVAI
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Sept 2025)
What this means for you
This application is over — abandoned 15 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97574025
- Mark type
- Stylized text
- Filed
- 31 Aug 2022
- Published for opposition
- 20 Jun 2023
- Abandoned
- 15 Sept 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; drug discovery services making and using computationally derived three-dimensional models of biological molecules, including proteins and other macromolecules, for purposes of drug discovery and development
Owner
- Gandeeva Therapeutics, Inc., Seattle, WA, US
- Gandeeva Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 15 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2025 — SOU EXTENSION 3 GRANTED
- 11 Feb 2025 — SOU EXTENSION 3 FILED
- 11 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2024 — SOU EXTENSION 2 GRANTED
- 06 Aug 2024 — SOU EXTENSION 2 FILED
- 06 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 10 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2024 — SOU EXTENSION 1 GRANTED
- 09 Feb 2024 — SOU EXTENSION 1 FILED
- 09 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT